Name | Number of supported studies | Average coverage | |
---|---|---|---|
plasma cell | 20 studies | 47% ± 19% | |
naive B cell | 18 studies | 40% ± 16% | |
B cell | 17 studies | 30% ± 10% | |
ciliated cell | 13 studies | 31% ± 12% | |
plasmablast | 10 studies | 44% ± 22% | |
memory B cell | 8 studies | 24% ± 7% | |
IgA plasma cell | 7 studies | 34% ± 10% | |
IgG plasma cell | 7 studies | 32% ± 10% | |
epithelial cell | 7 studies | 41% ± 17% | |
goblet cell | 6 studies | 32% ± 13% | |
endothelial cell | 5 studies | 21% ± 3% | |
fibroblast | 5 studies | 21% ± 6% | |
abnormal cell | 4 studies | 22% ± 8% | |
luminal cell of prostate epithelium | 4 studies | 29% ± 9% | |
oligodendrocyte precursor cell | 4 studies | 19% ± 4% | |
basal cell | 4 studies | 28% ± 13% | |
GABAergic neuron | 3 studies | 24% ± 6% | |
glutamatergic neuron | 3 studies | 20% ± 4% | |
enteroendocrine cell | 3 studies | 33% ± 15% | |
intestinal crypt stem cell | 3 studies | 20% ± 2% | |
connective tissue cell | 3 studies | 33% ± 17% | |
immature B cell | 3 studies | 42% ± 17% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
pancreas | 100% | 5809.20 | 328 / 328 | 100% | 35.22 | 178 / 178 |
prostate | 100% | 5273.09 | 245 / 245 | 100% | 145.86 | 502 / 502 |
stomach | 100% | 2830.57 | 359 / 359 | 100% | 34.80 | 285 / 286 |
breast | 100% | 1833.82 | 459 / 459 | 100% | 68.58 | 1114 / 1118 |
lung | 100% | 1834.58 | 576 / 578 | 100% | 45.81 | 1152 / 1155 |
intestine | 100% | 1836.32 | 966 / 966 | 99% | 33.12 | 521 / 527 |
bladder | 100% | 1595.71 | 21 / 21 | 99% | 35.25 | 498 / 504 |
uterus | 100% | 1565.61 | 170 / 170 | 98% | 30.54 | 450 / 459 |
thymus | 100% | 2518.92 | 653 / 653 | 98% | 33.18 | 593 / 605 |
esophagus | 100% | 1224.91 | 1445 / 1445 | 97% | 28.87 | 178 / 183 |
brain | 98% | 1173.33 | 2602 / 2642 | 99% | 24.65 | 696 / 705 |
ovary | 100% | 1939.78 | 180 / 180 | 97% | 24.92 | 417 / 430 |
skin | 100% | 1302.50 | 1803 / 1809 | 95% | 24.32 | 447 / 472 |
adrenal gland | 100% | 1498.05 | 258 / 258 | 91% | 25.86 | 209 / 230 |
kidney | 100% | 1915.92 | 89 / 89 | 90% | 20.82 | 809 / 901 |
liver | 100% | 1810.31 | 225 / 226 | 74% | 17.52 | 301 / 406 |
spleen | 100% | 2923.56 | 241 / 241 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.01 | 1 / 1 |
adipose | 100% | 1369.95 | 1203 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 2016.51 | 1333 / 1335 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 93% | 22.58 | 42 / 45 |
heart | 91% | 649.31 | 783 / 861 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 88% | 21.23 | 70 / 80 |
lymph node | 0% | 0 | 0 / 0 | 79% | 18.09 | 23 / 29 |
peripheral blood | 76% | 858.57 | 703 / 929 | 0% | 0 | 0 / 0 |
muscle | 48% | 235.51 | 382 / 803 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006644 | Biological process | phospholipid metabolic process |
GO_0046839 | Biological process | phospholipid dephosphorylation |
GO_0005886 | Cellular component | plasma membrane |
GO_0016020 | Cellular component | membrane |
GO_0005737 | Cellular component | cytoplasm |
GO_0000810 | Molecular function | diacylglycerol diphosphate phosphatase activity |
GO_0008195 | Molecular function | phosphatidate phosphatase activity |
GO_0005515 | Molecular function | protein binding |
Gene name | PLPP5 |
Protein name | Phospholipid phosphatase 5 Phospholipid phosphatase 5 (EC 3.1.3.4) (EC 3.6.1.75) (Phosphatidic acid phosphatase type 2 domain-containing protein 1B) |
Synonyms | PPAPDC1B DPPL1 HTPAP |
Description | FUNCTION: Magnesium-independent phospholipid phosphatase with broad substrate specificity . Preferentially catalyzes the conversion of diacylglycerol pyrophosphate into phosphatidate but can also act on phosphatidate and lysophosphatidate . Phospholipid phosphatases are involved in both the synthesis of lipids and the generation or degradation of lipid-signaling molecules . . |
Accessions | ENST00000419686.2 [Q8NEB5-4] ENST00000531109.5 H0YDY2 ENST00000422581.6 [Q8NEB5-2] H0YCQ3 ENST00000531823.5 ENST00000424479.7 [Q8NEB5-1] E9PNB1 ENST00000524616.5 Q8NEB5 H0YCK0 ENST00000534339.5 ENST00000529359.5 [Q8NEB5-3] |